IBCN   20355
INSTITUTO DE BIOLOGIA CELULAR Y NEUROCIENCIA "PROFESOR EDUARDO DE ROBERTIS"
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Setting Up an In Vitro Model to Study Glial Response to Peripheric Immune Cells
Autor/es:
ALBERTO JAVIER RAMOS; VERONICA MURTA
Lugar:
Córdoba
Reunión:
Congreso; XXXIII Congreso Anual de la Sociedad Argentina de Investigación en Neurociencias; 2018
Institución organizadora:
Sociedad Argentina de Investigación en Neurociencias
Resumen:
Healthy central nervous system provides limited interaction between parenchymal astrocytes and immune peripheral cells. After an ischemic event, the blood?brain barrier is compromised and leukocytes are drawn to the lesion, where a complex immune response arises involving both local and systemic cells. The detrimental or beneficial roles of this recruitment are still discussed. The aim of the present work is to shed some light on the systemic cues associated with the commitment of astrocytes to specific activating profiles in response to peripheral immune cells. To undertake this challenge, we set up an in vitro model where primary rat glial cells are co-cultured with eGFPþ leukocytes isolated from adult Wistar-TgN(CAG-GFP)184ys rats. Fixed leukocytes were used to analyze the effect of surface molecules.Using immunofluorescence, we evaluated astrocyte reactivity (GFAP), microglial activation (Iba1), and the formationof glial scar-like structures. Short-term (6 hr) and long-term (72 hr) effects were studied. Astrocytes in contact with both fresh and fixed leukocytes had a fibrillar morphology and increased GFAP expression. Cellular retraction and reorganization was evident, and scar-like structures were seen. Microglia in contact with leukocytes had an activated (round) morphology. These results indicate that both soluble factors and surface molecules in leukocytes are capable of inducing astrocytes? reactivity, but further research is necessary to determine more specific pathways involved.This work was supported by PICT2015-1451-UBACYT.